Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ECMO on hydromorphone pharmacokinetics
ChiCTR2200055727Phase 4Recruiting
- Sponsor
- Union Hospital of Huazhong University of Science and Technology
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hydromorphone in pain and Acute critical illness (ACI), sponsored by Union Hospital of Huazhong University of Science and Technology. Primary endpoint: pharmacokinetics of hydromorphone during ECMO. Started Feb 2022; status: recruiting.
02
Drugs
hydromorphone
03
Conditions
painAcute critical illness (ACI)
Beyond the preview
Go deeper on ChiCTR2200055727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055727.